Rare Aggressive Form of Multiple Myeloma with Diffuse Osteosclerosis and Elevated CA 15-3 Levels
- 1 Department of Hematology, Ziv Medical Center, Zefat, Israel
- 2 Department of Internal Medicine, Ziv Medical Center, Zefat, Israel
- 3 Department of Radiology, Ziv Medical Center, Zefat, Israel
- 4 Clalit Health Service, Akko, Israel
- 5 Faculty of Medicine in the Galilee, Bar-Ilan University, Safed, Israel
Abstract
We report the case of a 56-year-old female who had recently been examined for back and epigastric pain, and was diagnosed in the internal medicine ward as having an aggressive rare form of multiple myeloma with diffuse osteoblastic bone lesions. She also had high levels of breast tumor marker (CA 15-3), severe tumor lysis syndrome, and pleural and central nervous system involvement. A few cases of multiple myeloma with diffuse osteosclerosis that are not part of POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, skin changeshave) have been described. None of these cases were as aggressive as our case. To our knowledge it is the first report describing an elevation in CA 15-3 in conjunction with multiple myeloma.
- Kyle, R.A., Gertz, M.A., Witzig, T.E., Lust, J.A., et al. (2003) Review of 1027 Patients with Newly Diagnosed Multiple Myeloma. Mayo Clinic Proceedings, 78, 21-33. http://dx.doi.org/10.4065/78.1.21
- Blaquière, R.M., Guyer, P.B., Buchanan, R.B. and Gallagher, P.J. (1982) Sclerotic Bone Deposits in Multiple Myeloma. The British Journal of Radiology, 55, 591-593. http://dx.doi.org/10.1259/0007-1285-55-656-591
- Lacy, M.Q., Gertz, M.A., Hanson, C.A., Inwards, D.J. and Kyle, R.A. (1997) Multiple Myeloma Associated with Diffuse Osteosclerotic Bone Lesions: A Clinical Entity Distinct from Osteosclerotic Myeloma (POEMS Syndrome). American Journal of Hematology, 56, 288-293. http://dx.doi.org/10.1002/(SICI)1096-8652(199712)56:4 3.0.CO;2-5
- Patoliaa, S., Schmidta, F., Patoliaa, S., Gulati, N., Muhammad, P., Narendra, D., Enriquez, D. and Quist, J. (2012) Multiple Myeloma with Mixed Lytic and Blastic Bone Lesions with Lymphadenopathy: Rare Manifestation of a Common Disease-Case Presentation and Literature Review. World Journal of Oncology, 3, 78-82. http://dx.doi.org/10.4021/wjon440w
- Shering, S.G., Sherry, F., McDermott, E.W., O’Higgins, N.J. and Duffy, M.J. (1998) Preoperative CA15-3 Concentrations Predict Outcome of Patients with Breast Carcinoma. Cancer, 83, 2521-2527. http://dx.doi.org/10.1002/(SICI)1097-0142(19981215)83:12 3.0.CO;2-A